Early sodium‐glucose co‐transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome
Muhammad Usman Shah,
Joanna Kate Ward,
Alun Roebuck,
Bala Srinivasan,
Paul Edward Squires,
Claire Elizabeth Hills,
Maxime Inghels,
Kelvin Lee
Wiley ·
2026-10-27
· DOI 10.1111/dme.70480
⬢ Цитируемость: 1Crossref
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Muhammad Usman Shah, Joanna Kate Ward, Alun Roebuck, Bala Srinivasan, Paul Edward Squires, Claire Elizabeth Hills et al. Early sodium‐glucose co‐transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome. // Diabetic Medicine. – 2026. – DOI: 10.1111/dme.70480. – URL: https://onlinelibrary.wiley.com/doi/10.1111/dme.70480?af=R
Muhammad Usman Shah, Joanna Kate Ward, Alun Roebuck, Bala Srinivasan, Paul Edward Squires, Claire Elizabeth Hills, Maxime Inghels, & Kelvin Lee (2026). Early sodium‐glucose co‐transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome. Diabetic Medicine. https://doi.org/10.1111/dme.70480
Muhammad Usman Shah, et al. “Early sodium‐glucose co‐transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome.” Diabetic Medicine, 2026. doi:10.1111/dme.70480.
@article{Shah2026,
title = {Early sodium‐glucose co‐transporter 2 inhibitor initiation is associated with improved cardiovascular outcomes in type 2 diabetes and acute coronary syndrome},
author = {Shah, Muhammad Usman and Ward, Joanna Kate and Roebuck, Alun and Srinivasan, Bala and Squires, Paul Edward and Hills, Claire Elizabeth and Inghels, Maxime and Lee, Kelvin},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70480},
url = {https://onlinelibrary.wiley.com/doi/10.1111/dme.70480?af=R}
}